1. Home
  2. GAUZ vs QNCX Comparison

GAUZ vs QNCX Comparison

Compare GAUZ & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • QNCX
  • Stock Information
  • Founded
  • GAUZ 2009
  • QNCX 2012
  • Country
  • GAUZ Israel
  • QNCX United States
  • Employees
  • GAUZ N/A
  • QNCX N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GAUZ Miscellaneous
  • QNCX Health Care
  • Exchange
  • GAUZ Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • GAUZ 109.1M
  • QNCX 90.8M
  • IPO Year
  • GAUZ 2024
  • QNCX 2019
  • Fundamental
  • Price
  • GAUZ $5.70
  • QNCX $1.63
  • Analyst Decision
  • GAUZ Strong Buy
  • QNCX Strong Buy
  • Analyst Count
  • GAUZ 3
  • QNCX 6
  • Target Price
  • GAUZ $13.67
  • QNCX $8.00
  • AVG Volume (30 Days)
  • GAUZ 60.7K
  • QNCX 204.4K
  • Earning Date
  • GAUZ 08-13-2025
  • QNCX 08-11-2025
  • Dividend Yield
  • GAUZ N/A
  • QNCX N/A
  • EPS Growth
  • GAUZ N/A
  • QNCX N/A
  • EPS
  • GAUZ N/A
  • QNCX N/A
  • Revenue
  • GAUZ $96,810,000.00
  • QNCX N/A
  • Revenue This Year
  • GAUZ $28.49
  • QNCX N/A
  • Revenue Next Year
  • GAUZ $47.77
  • QNCX N/A
  • P/E Ratio
  • GAUZ N/A
  • QNCX N/A
  • Revenue Growth
  • GAUZ 7.87
  • QNCX N/A
  • 52 Week Low
  • GAUZ $5.15
  • QNCX $0.61
  • 52 Week High
  • GAUZ $13.00
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ 36.11
  • QNCX 47.46
  • Support Level
  • GAUZ $5.15
  • QNCX $1.59
  • Resistance Level
  • GAUZ $6.00
  • QNCX $1.93
  • Average True Range (ATR)
  • GAUZ 0.36
  • QNCX 0.13
  • MACD
  • GAUZ -0.02
  • QNCX -0.02
  • Stochastic Oscillator
  • GAUZ 36.88
  • QNCX 25.00

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: